100 related articles for article (PubMed ID: 31055868)
21. The expression of Dicer and Drosha in matched normal tissues, tumours and lymph node metastases in triple negative breast cancer.
Avery-Kiejda KA; Braye SG; Forbes JF; Scott RJ
BMC Cancer; 2014 Apr; 14():253. PubMed ID: 24725360
[TBL] [Abstract][Full Text] [Related]
22. Expression of the ribonucleases Drosha, Dicer, and Ago2 in colorectal carcinomas.
Papachristou DJ; Korpetinou A; Giannopoulou E; Antonacopoulou AG; Papadaki H; Grivas P; Scopa CD; Kalofonos HP
Virchows Arch; 2011 Oct; 459(4):431-40. PubMed ID: 21769619
[TBL] [Abstract][Full Text] [Related]
23. Expression of Dicer and Drosha in triple-negative breast cancer.
Passon N; Gerometta A; Puppin C; Lavarone E; Puglisi F; Tell G; Di Loreto C; Damante G
J Clin Pathol; 2012 Apr; 65(4):320-6. PubMed ID: 22259182
[TBL] [Abstract][Full Text] [Related]
24. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
Han Y; Liu Y; Gui Y; Cai Z
J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
[TBL] [Abstract][Full Text] [Related]
25. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer.
Faggad A; Kasajima A; Weichert W; Stenzinger A; Elwali NE; Dietel M; Denkert C
Histopathology; 2012 Oct; 61(4):552-61. PubMed ID: 22716222
[TBL] [Abstract][Full Text] [Related]
26. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
27. Major regulators of microRNAs biogenesis Dicer and Drosha are down-regulated in endometrial cancer.
Torres A; Torres K; Paszkowski T; Jodłowska-Jędrych B; Radomański T; Książek A; Maciejewski R
Tumour Biol; 2011 Aug; 32(4):769-76. PubMed ID: 21559780
[TBL] [Abstract][Full Text] [Related]
28. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma.
Vidulich KA; Talpur R; Bassett RL; Duvic M
Int J Dermatol; 2009 Mar; 48(3):243-52. PubMed ID: 19261011
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of the endoribonucleases Drosha, Dicer and Ago2 in smooth muscle tumours of soft tissues.
Papachristou DJ; Sklirou E; Corradi D; Grassani C; Kontogeorgakos V; Rao UN
Histopathology; 2012 May; 60(6B):E28-36. PubMed ID: 22394132
[TBL] [Abstract][Full Text] [Related]
30. Expression of DROSHA and DICER genes in peripheral blood leukocytes in lung sarcoidosis.
Malysheva IE; Balan OV; Tikhonovich EL; Volkova TO
Ter Arkh; 2018 Apr; 90(3):21-24. PubMed ID: 30701851
[TBL] [Abstract][Full Text] [Related]
31. Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.
Dusílková N; Bašová P; Polívka J; Kodet O; Kulvait V; Pešta M; Trněný M; Stopka T
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036928
[TBL] [Abstract][Full Text] [Related]
32. Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances.
Shu GS; Yang ZL; Liu DC
Pathol Res Pract; 2012 Jul; 208(7):392-7. PubMed ID: 22658478
[TBL] [Abstract][Full Text] [Related]
33. Expression of MCM-3 and MCM-7 in Primary Cutaneous T-cell Lymphomas.
Jankowska-Konsur A; Kobierzycki C; Reich A; Grzegrzolka J; Maj J; Dziegiel P
Anticancer Res; 2015 Nov; 35(11):6017-26. PubMed ID: 26504025
[TBL] [Abstract][Full Text] [Related]
34. Perturbation of DROSHA and DICER expression by human papillomavirus 16 oncoproteins.
Harden ME; Munger K
Virology; 2017 Jul; 507():192-198. PubMed ID: 28448850
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of microRNA biogenesis machinery: Drosha, DGCR8 and Dicer in multiple sclerosis patients.
Jafari N; Shaghaghi H; Mahmoodi D; Shirzad Z; Alibeiki F; Bohlooli S; Dogaheh HP
J Clin Neurosci; 2015 Jan; 22(1):200-3. PubMed ID: 25439752
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of c-myb in leukaemic and non-leukaemic variants of cutaneous T-cell lymphoma.
Poenitz N; Simon-Ackermann J; Gratchev A; Qadoumi M; Klemke CD; Stadler R; Kremer A; Radenhausen M; Henke U; Assaf C; Utikal J; Goerdt S; Dippel E
Dermatology; 2005; 211(2):84-92. PubMed ID: 16088151
[TBL] [Abstract][Full Text] [Related]
37. Analysis of long-term outcomes of combined modality therapy for cutaneous T-cell lymphoma.
Duvic M; Apisarnthanarax N; Cohen DS; Smith TL; Ha CS; Kurzrock R
J Am Acad Dermatol; 2003 Jul; 49(1):35-49. PubMed ID: 12833006
[TBL] [Abstract][Full Text] [Related]
38. Expression of the RNase III enzyme DROSHA is reduced during progression of human cutaneous melanoma.
Jafarnejad SM; Sjoestroem C; Martinka M; Li G
Mod Pathol; 2013 Jul; 26(7):902-10. PubMed ID: 23370771
[TBL] [Abstract][Full Text] [Related]
39. DICER and DROSHA gene expression and polymorphisms in autoimmune thyroid diseases.
Saeki M; Watanabe M; Inoue N; Tokiyoshi E; Takuse Y; Arakawa Y; Hidaka Y; Iwatani Y
Autoimmunity; 2016 Dec; 49(8):514-522. PubMed ID: 27808570
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of Drosha, DiGeorge syndrome critical region gene 8 (DGCR8), and Dicer mRNAs in the pathogenesis of psoriasis.
Rostami Mogaddam M; Safavi Ardabili N; Shafaeei Y; Maleki N; Jafari N; Jafari A
J Cosmet Dermatol; 2017 Dec; 16(4):e48-e53. PubMed ID: 28342199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
